RAP (ASX) Ann: Results from Data Confirmation Study

Originally posted by pilko3: ↑

that the screening tool required further testing/and yes sir Aras you have nailed the thing and have highlighted the real reason we look like we have been setup like fools with the whole way this Pfizer thing has been going down...listen up.
The large part of the capital from Pfizer was allocated for further study/testing/approval then commercialisation of this Covid screening tool.
The testing failed but wait...if RAP and Pfizer were aware that the Covid test required further testing and then had to be sent for approval they must have already been aware of the fact it was at that stage "less than perfect" to say the least. RAP had already stated the figures they had produced from their trials. But, they knew that the figures ere a tad wobbly as the Covid test required more work so the current figures were not the final figures achievable.
So did RAP and Pfizer then decide to use the retesting of the Covid screening tool knowing all the while the chances of the results being the same or better were indeed slim therefore the optional bid would end up being the lower of the two options chosen at 14.6 cents? IT would seem we have fallen victim to the old three card trick...pretending that an unknown (with the large chance of different results after testing) would swing Pfizer to the lower bid and be the justification for that swing.
They were going to work on knocking the screening tool for Covid test into shape by admission as this is what they declared that much of the Pfizer funding was going to be used for...retesting the Covid Screening tool.
TK comes out and says in his opinion the results should be OK for the Pfizer retest so we all breath some sort of collective sigh of relief. Since when does a test that requires further work, testing etc to ready it for approval all of a sudden become the only criteria for Pfizer (with TK's blessing note) to go off re keeping the bid of 20.7 cents or dropping it to 14.6 cents.
If this extremely pertinent fact can be proven nd shown to be true then it is IMHO a damning indictment as to how this whole buyout debacle has been handled and presented...the implications and dodgy treatment of the way the bid and conditions have been progressed would make any good legal eagle blush. The BOD could have painted themselves into a corner with not many avenues of excuse around this one point.
Thanks ARAS this point is just about as important as it gets on many levels. The test required further work and testing...however we can use it to facilitate getting the bid down to te lowest value as presented by the independent valuer...that's good, very good...we do like that. They will never see through this one. IMHO DYOR and stand by,,,

Expand

True

Pfizer at this point has become a liability for Resapp,

we are in fact better off without it

Go away Pfizer!

Leave Resapp alone. You are not welcome anymore.

HRZ

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

RHK

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

MIN

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

MND

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

NVA

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

TRP

(20min delay)
Last 20.5¢		Change 0.000(0.00%)		Mkt cap ! $176.2M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Results from Data Confirmation Study, page-350

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Featured News

Ann: Results from Data Confirmation Study, page-350

Top Stories

Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision

Red Hawk upgrades Blacksmith with DSO mineral resource at the Eagle Deposit

ASX Market Open: ASX200 to rise for Friday session | July 26

IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity

Nine's staff strike as Paris Olympic coverage begins

MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned

Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?

Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Featured News